Loading
BI
BioDlink International Co. Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Liu Jun, was filed 05 Jan 2023.
BioDlink International Co. Ltd. - B: what insiders have been doing
BioDlink International Co. Ltd. - B, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. The past year has been quiet: not a single insider filing for BioDlink International Co. Ltd. - B. The previous disclosure was published on 13 January 2023.
The full history, which starts in 2019, counts 3 purchases against 1 sale.
In the same sector, recent insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc also feature in our signals. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
3 ops. · all time
Sell Volume
€492,265
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,168 of 26,283 companies
30.3
score / 100
Value28
Quality33
FCF yld-1.1%
Earn yld-3.9%
EV/EBITDA·
ROE-24%
Gross mgn52%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$3.52
Analyst consensus
1 analystsHK$4.46Target HK$4.46(+27%)HK$4.46
Income statement
RevenueHK$747.6M
Gross profitHK$389M52% margin
EBITDA-HK$9.3M-1% margin
Net income-HK$100.4M-32.3% margin
Valuation
PER (forward)50.2x
P/Book3.8x
Beta-0.11
Balance sheet & cash
Market capHK$2.5B
Total debtHK$383.6M
Free Cash Flow-HK$26.9M
Debt / Equity57%
Profitability & ownership
ROE-24.2%
ROA-6.7%
% insiders69.0%
% institutions8.9%
Last declaration on 13 January 2023
Declarations5 total
1,650,000 shares@ HK$2.50100.0% of flowShareXHKGHKEX:DA20230113E00600
2,897,383 sharesShareXHKGHKEX:DA20210127E00575
Canonical exit: 28 Mar 2021 (T+90)
2,037,500 sharesShareXHKGHKEX:DA20191121E00203
5 of 5 declarations
About BioDlink International Co. Ltd. - B
BioDlink International Co. Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the biotechnology sector. It focuses on developing innovative solutions for the healthcare industry.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
